SCHEMBL464808

SCHEMBL464808

O=C(OO)[C@@H]1CCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1268174 1.00
SCHEMBL388496 1.00
SCHEMBL28080548 0.93 NOS2 (0.39)
SCHEMBL2494402 0.84 NOS2 (0.43)
SCHEMBL6859669 0.84 NOS2 (0.46)
SCHEMBL995604 0.84 NOS2 (0.46)
SCHEMBL146828 0.84 NOS2 (0.46)
SCHEMBL2637808 0.83 NOS2 (0.42)
Proline SCHEMBL8941802 0.82 BLM (0.47)
SCHEMBL4336849 0.81 EPHX1 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1627 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250187998-A1 IDENTIFICATION OF SOIL BACTERIA-ENRICHING AGENTS AND METHODS OF USE THEREOF CALIFORNIA INSTITUTE OF TECHNOLOGY 2025-06-12 US claimed
US-12173330-B2 Method for producing hydroxy-L-pipecolic acid API CORPORATION (JP) 2024-12-24 US claimed
US-20240318124-A1 PREDICTIVE CELL-BASED FED-BATCH PROCESS JANSSEN BIOTECH, INC. 2024-09-26 US claimed
US-12098217-B2 Fusion peptides as antimicrobial agents CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2024-09-24 US claimed
EP-4403042-A2 FLAVOR COMPOSITIONS AND PET FOOD PRODUCTS CONTAINING THE SAME Mars, Incorporated (US) 2024-07-24 EP claimed
US-12031152-B2 Nutrient media for the production of slaughter-free meat UPSIDE FOODS, INC. (US) 2024-07-09 US claimed
EP-3229612-B1 USE OF FLAVOR COMPOSITIONS AND PET FOOD PRODUCTS CONTAINING THE SAME MARS INC (US) 2024-06-26 EP claimed
CN-115466251-B Condensed heterocyclic compound, preparation method, pharmaceutical composition and application thereof 中国医学科学院药物研究所 2024-06-21 CN claimed
EP-4370649-A1 PREDICTIVE CELL-BASED FED-BATCH PROCESS Janssen Biotech, Inc. (US) 2024-05-22 EP claimed
CN-117965630-A Novel feed production process of HPV16 virus-like particles in SF9 cells 无锡多宁生物科技有限公司 2024-05-03 CN claimed
WO-2000015789-A1 RECOMBINANT BIOADHESIVE PROTEIN ANALOGS COMPRISING HYDROXYPROLINE UNITED STATES SURGICAL CORPORATION (US) 2000-03-23 WO claimed
EP-0953041-A1 SERUM-FREE MAMMALIAN CELL CULTURE MEDIUM, AND USES THEREOF LIFE TECHNOLOGIES, INC. (US) 1999-11-03 EP claimed
WO-1998008934-A9 SERUM-FREE MAMMALIAN CELL CULTURE MEDIUM, AND USES THEREOF LIFE TECHNOLOGIES INC (US) 1999-04-22 WO claimed
WO-1998008934-A1 SERUM-FREE MAMMALIAN CELL CULTURE MEDIUM, AND USES THEREOF LIFE TECHNOLOGIES, INC. (US) 1998-03-05 WO claimed
EP-0791071-A1 ASSAY FOR PROLINE IMINOPEPTIDASE AND OTHER HYDROLYTIC ACTIVITIES LITMUS CONCEPTS, INC. (US) 1997-08-27 EP claimed
US-5571684-A SOLID PHASE CONJUGATE LITMUS CONCEPTS, INC. (US) 1996-11-05 US claimed
CN-1133563-A Novel tripeptides useful in immune and Central Nervous System (CNS) therapy IMMUNOBIOLOGY RES INST INC (US) 1996-10-16 CN claimed
WO-1996015255-A2 ASSAY FOR PROLINE IMINOPEPTIDASE AND OTHER HYDROLYTIC ACTIVITIES LITMUS CONCEPTS, INC. (US) 1996-05-23 WO claimed
US-5334517-A Cultivating microorganism of genus clonostachys, gliocladium and nectria; used for synthesis of cabapenem antibiotics SANKYO COMPANY LIMITED (JP) 1994-08-02 US claimed
EP-0076647-A2 Culture media for cells originating from the immune system HANA Biologics Incorporated (US) 1983-04-13 EP claimed